Trials / Completed
CompletedNCT01209949
Assessment of Subjects' Efficacy and Experiences Using Adapalene BPO Gel in the Treatment of Acne Vulgaris
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 30 (actual)
- Sponsor
- Galderma R&D · Industry
- Sex
- All
- Age
- 16 Years – 25 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to assess subjects' experiences using Adapalene BPO gel to treat mild to moderate acne vulgaris using efficacy measurements, quality of life instruments, and video diaries.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Adapalene 0.1% and Benzoyl Peroxide 2.5% gel | Apply adapalene BPO gel once daily in the evening for 12 weeks |
Timeline
- Start date
- 2010-10-01
- Primary completion
- 2011-01-01
- Completion
- 2011-01-01
- First posted
- 2010-09-27
- Last updated
- 2022-08-01
- Results posted
- 2012-01-19
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01209949. Inclusion in this directory is not an endorsement.